Try our Advanced Search for more refined results
Life Sciences - December, 2011
152 articles
- Doctors Seek High Court Reversal Of DNA Patentability
- Bristol-Myers Escapes Navy Encryption IP Suit
- FDA Warns Of New Baby Acetaminophen Dosage Risks
- Santarus Tries To Shoot Down Zydus' Generic Zegerid
- Canada, EU To Probe Novartis Diabetes Drug
- Hospira Investors Go After Board Over Inflated Stock Prices
- DNA Probe Patent Suit Belongs In California: Fed. Circ.
- HGS Execs Hid Lupus Drug's Suicide Link: Suit
- Sanofi, Sun Settlement Ends Plavix Patent Case
- Ripe For Comment: The CMS Sunshine Rule
- Black & Decker, Others Sued For Dump Site Cleanup Costs
- In Pursuit Of Financial Fraudsters
- J&J Targets 12M Bottles Of Motrin In Latest Recall
- Wal-Mart Pulls Enfamil Formula After Infant Death
- Novartis, Others Can't Stop Generic Tobramycin Suit
- SC AG Can't Skirt AstraZeneca Improper Penalty Claims
- Tris Pharma Kicks Cough Syrup Infringement Claims
- Genentech Sues Dr. Reddy's Over Generic Valcyte
- Kelley Drye Lands 2 Schiff Hardin IP Partners
- Immersion Beats $300M Suit Over Pumped-Up Stock Prices
- French Doctor Gets Time Served For Insider Trading
- House Asks DHS To Fork Over Docs On $433M SIGA Deal
- Judge Won't Nix $327M Verdict Over J&J's Risperdal
- Ranbaxy Settles With FDA, Sets Aside $500M For DOJ Probe
- Bard Picks Up Device Maker Lutonix For $325M
- France Calls For Removal Of 30,000 Breast Implants
- Merck Reaches $24M Deal To End Mass. Medicaid Suit
- Ex-NFL Player Fronted Heart Device Co. Stock Scam: SEC
- New VC Fund To Invest $75M In Early-Stage Health Cos.
- Pfizer, Sandoz Agree To End Caduet Patent Fight
- Judge Trims J&J Investor Suit Over Kids' Meds Recalls
- Smith & Nephew's $85M Win Axed In Suture Anchor IP Row
- SIGA Can't Scrap Smallpox Drug Profit-Share Ruling
- Rejecting Brand-Liability Theory Post-Mensing
- FDA Tightens Restrictions On Sanofi's Multaq
- FCA Recoveries Top $3B For 2nd Year In A Row
- Pfizer, Others To Shell Out $6M For Superfund Cleanup
- Pfizer Seeks To Stymie Sandoz, Accord's Generic Torisel
- HHS To Let States Set Benefit Benchmarks For Health Plans
- New FDA Rules To Up Women In Medical Device Studies
- Sens. Float Bill To Improve Watch Over Medical Devices
- KV Again Shakes Suit Over Metoprolol Recall
- Scrutinizing Reverse-Payment Settlements
- Shire Takes Aim At Mylan Again In New Intuniv Patent Suit
- Kimberly-Clark Sues Cardinal Over Sterilization Wrap IP
- J&J Unit Aims To Thwart Sandoz's Generic Doribax
- Teva Unit Targets Celgene Breast Cancer Drug In IP Suit
- Shearman Aids Fujifilm In $995M Buy Of Ultrasound Co.
- J&J Unit Hits Covidien With Surgical Tool Patent Suit
- Covidien To Separate $2B Pharmaceuticals Unit
- Cipro Pay-For-Delay Suit Heads To Calif. High Court
- Merck Sells NJ Office Building To PE Venture
- Cancer Institute Says Doctor Stole $1B In Research
- JPML Won't Merge 12 Actions Over Plavix Injuries
- Sealing The Deal: Skadden Splits Diabetes Drug Alliance
- Martek Can't Duck Baby Formula Ingredients Antitrust Suit
- Bayer's Off-Label Yaz Marketing Violated FCA: Watchdog
- Widening The Class Certification Circuit Split
- Biotech REIT Scores Boston Lab Complex For $308M
- Watson Pays $27M To Exit Drug Inflation MDL
- DOJ Sets Record-High $6B Fraud Recovery In 2011
- DOJ Seeks To Add $1M To Mass. $13M Cleanup Settlement
- Ironwood Lied To Patent Offices: $500M Suit
- FDA Blasts Medical Centers Over Deceptive Lap-Band Ads
- FDA Ducks Contempt Claim After Nixing OTC Contraceptives
- Warner Chilcott Takes Aim At Lupin's Generic Generess Fe
- Baxter Scoops Up Synovis For $325M
- 4th Exec Jailed For Illicit Human Testing Of Bone Cement
- Sidley Austin Welcomes Greenberg IP Pro To SF Office
- The No-Injury Warranty Claims Quandary
- Determining Patentability Of Personalized Medicine
- Merck Urges 3rd Circ. To OK Pay-For-Delay Settlements
- Medtronic Investors Win Cert. In Off-Label Marketing Case
- Medtronic Strikes $23.5M Deal In Doctor Kickbacks Dispute
- Gibson Dunn Lures New FDA Practice Leader From Sidley
- Impax's Generic Amrix Must Stay Banned: Cephalon, Mylan
- Symmetry Picks Up J&J Unit's Surgical Tool Line For $165M
- Pharmacies' Pfizer Merger Appeal Stays Out Of High Court
- Valeant Cedes Drugs To Win OK For $770M Skin Care Buys
- Fed. Circ. Nixes Injunction On Mylan's Generic Doryx
- Vaccine Purchasers Accuse Sanofi Of Stifling Competition
- SEC Targets Glaxo Unit Over Underpriced Stock Buybacks
- Teva Settles Suit Over Watson's Generic LoSeasonique
- Ex-Shionogi IT Employee Gets 3.5 Years For Hacking
- Valeant Ends Fight With Par Over Generic Antidepressant
- Hospira Misled Investors To Pump Up Stock Prices: Suit
- FTC, Boehringer Wrangle Over Generics Settlement Docs
- Australia To Step Up Regulation Of Homeopathics
- Merck Scores Patent Extension Win In EU High Court
- 6th Circ. Backs Ex-B. Braun Worker In Off-Label Drug Case
- Two Firsts In Post-Mensing Litigation
- Pfizer Settles Menopause Drug Suit After $73M Verdict
- How To Tell Auditors About A Fraud Investigation
- Bayer Should Stress Clot Risk On Yaz Label: FDA Panel
- Wal-Mart Launches FCPA Compliance Probe
- American Laser Heads To Ch. 11 To Ease Sale
- Calif. AG Seeks Medtronic Bone Graft Docs
- Pfizer Sues Alembic Over Lyrica ANDA
- Novartis, Celgene Hit Teva Again Over ADHD Drug Patents
- UK Pushes Full Exam For $7.8B Private Medical Industry
- LabCorp's $85M Orchid Deal Depends On Divestment: FTC
- Nutter Pulls In Former Pfizer Patent Pro
- Fed. Circ. Affirms Cephalon Win In Generic Fentora IP Suit
- Brand's Off-Label Promotion: Valuable Tool For Generics
- Covert Investigations And Ethical Considerations
- J&J, Coloplast, Others Face Cancer Treatment Patent Suit
- High Court Ponders Limits Of Patentability In Mayo Suit
- Drugmakers Sue Wockhardt Over Tricor ANDA
- House OKs Bill To Boost Congress' Power Over Regulations
- HealthpointCapital Takes On Surgical Tool Maker Blue Belt
- Lab-Focused REIT Nets $600M Loan To Restructure Debt
- Humana Picks Up Health Analytics Leader Anvita
- Bayer Battles Generic Yasmin Hopeful In Fed. Circ.
- Medline Seeks To Avoid Bill For Surgical Mesh Suits
- Plan B Birth Control Still Requires Prescription, HHS Says
- Lannett Cuts Deal With Celgene In Thalomid Antitrust Case
- Caraco V. Novo Nordisk — A Divided Supreme Court
- Conditions Of Participation And Payment As Qui Tam Defense
- Buying A Distressed Hospital Out Of Bankruptcy
- Pfizer Hit With $73M Verdict In Menopause Drug Suit
- Lupin Must Halt Sales Of Generic Diabetes Drug: Judge
- Express Scripts Exec Defends $29B Merger To Lawmakers
- FDA Eases Risk Mandates For GSK, Amgen Platelet Drugs
- FDA To Weigh Public Input On Biosimilars Program
- KV Pharma To Shell Out $17M In FCA Settlement
- Shire Patent Suit Dismissal Will Delay Generic: Alkem
- J&J Pays $2M To Exit Idaho AG's Drug Pricing Suit
- Software Co. SuccessFactors Buys Jobs2Web For $110M
- Targeting Health Care Execs Under Park Doctrine
- Bayer Covered Up Yasmin Blood Clot Risk: Ex-FDA Head
- GOP Sens. Urge FTC To Probe $29B Express Scripts Merger
- Class Attys Get $1.5M In Allstate Cancer Policy Settlement
- Hatch-Waxman Provision Splits High Court In Generics Row
- UK Plan To Share Patient Data With Drug Industry Draws Ire
- Nixon Peabody Wins Over FDA Insider From Reed Smith
- Roche Scoops Up Verum Diagnostica
- Sanofi Presses Fed. Circ. To Nix Dr. Reddy's Allegra Win
- A Sign Of Future Biosimilars Litigation?
- High Court To Tackle Novo Nordisk's Generic Drug Fight
- Judge Refuses To Lift Ban On Generic Lovenox
- Pfizer Can't Shake Birth Defect Suit Over Worker's Child
- Mayo Case Could Clarify Patentability, Expand On Bilski
- Davis & Gilbert Botched Dance Film Copyright: $8M Suit
- Stent Wars: Return Of The Lost Patent
- Hagens Berman Off Hook In Ala. Firm's Atty Fee Battle
- Spectralytics Adds To $22M IP Verdict Against Cordis
- House Bill Would Open Door To Private FCPA Suits
- The Murky Waters Of Off-Label Liability
- Fed. Circ. Keeps Teva Out Of Luck Over Crestor Patent
- Walgreen, Kroger Join Fray Over Wyeth's Effexor Tactics
- Carlyle Unit Adds French Medical Casting Biz
- Bausch & Lomb Snaps Up Argentinian Contacts Co.